A biotechnology company designing immunotherapies for solid tumor cancers with a patient’s white blood cells is raising $80 million in its initial public offering or IPO. . . . → Read More: Cancer Immunotherapy Biotech Issues $80M IPO
|
|||||
       |
 Comments are closed  Finance  biomedical, biotechnology, cancer, clinical trials, equity, FDA, investment, IPO, licensing, pharmaceuticals, venture capital 
A treatment for HIV taken just once, using the genome-editing technology Crispr, is receiving fast-track designation from the U.S. Food and Drug Administration. . . . → Read More: One-Time Crispr HIV Therapy Given Fast-Track Status Comments are closed New products, Regulations biomedical, biotechnology, chemistry, clinical trials, FDA, genomics, health care, HIV, licensing, life sciences, pharmaceuticals, physical sciences, university 
A clinical trial is recruiting participants to assess the safety and feasibility of a system for spray drying and re-constituting a person’s blood plasma. . . . → Read More: Trial Underway Testing Dried Plasma for Transfusions Comments are closed New products biomedical, clinical trials, engineering, licensing, life sciences, medical device, physical sciences 
A new U.S. patent, licensed to a start-up biotechnology company, describes processes for linking together chains of synthetic peptides into therapeutic proteins. . . . → Read More: Patent Issued for Synthetic Peptide Chain Techniques One comment - (Comments are closed) Intellectual property biomedical, biotechnology, chemistry, engineering, entrepreneurs, genomics, licensing, life sciences, materials science, patent, pharmaceuticals, physical sciences, university, USPTO 
A developer of fusion energy for space travel and software company for space flight systems are writing machine learning algorithms to design a hyper-fast rocket engine. . . . → Read More: Companies Partner on A.I., Fusion Energy for Space Flight One comment - (Comments are closed) Joint ventures/collaborations, New products computer science, energy, engineering, licensing, mathematics, NASA, physical sciences, physics, software, space, U.K., university 
A developer of nanoscale lipid particles for delivering genomic therapies to specific cells and tissue, spun-off from academic labs, is raising $25 million in seed funds. . . . → Read More: Targeted Genetic Nanoparticle Company Gains $25M in Seed Funds One comment - (Comments are closed) Finance, New products biomedical, biotechnology, chemistry, engineering, entrepreneurs, equity, genomics, investment, licensing, life sciences, nanotechnology, pharmaceuticals, physical sciences, preclinical, university, venture capital 
A global drug maker is acquiring access to a biotechnology company’s precise genome editing techniques to develop new therapies for rare and cardiometabolic disorders. . . . → Read More: Pharma Company Gains Precise Gene Edits in $2B Biotech Deal 
A clinical trial shows a peel-and-stick patch device is as effective as a standard syringe injection in delivering a vaccine that protects against measles and rubella. . . . → Read More: Measles-Rubella Patch Vaccine Shown Effective as Injection One comment - (Comments are closed) New products Africa, biomedical, chemistry, clinical trials, engineering, entrepreneurs, health care, licensing, medical device, pharmaceuticals, physical sciences, university 
Two biotechnology companies are collaborating on creating genetic therapies delivered with lipid nanoscale particles using non-viral mechanisms to reach target cells. . . . → Read More: Moderna, Biotech Partner on Non-Viral Genetic Drug Delivery One comment - (Comments are closed) Intellectual property, Joint ventures/collaborations biomedical, biotechnology, chemistry, engineering, equity, genomics, investment, licensing, life sciences, nanotechnology, pharmaceuticals, physical sciences 
A new company making antibodies that degrade disease-causing proteins on and outside cell surfaces is raising $50 million in its first venture funding round. . . . → Read More: Start-Up Licenses Protein Therapy Tech, Raises $50M One comment - (Comments are closed) Finance, Intellectual property, New products biomedical, biotechnology, chemistry, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, physical sciences, university, venture capital |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts